The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats

Endocrinology

Volumn 138, Issue 11, 1997, Pages 4607-4612

  Dobnig, Harald ^a   Turner, Russell T ^b  

^a UNIVERSITY OF GRAZ   (Austria)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE[1-34];

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE METABOLISM; CALCIUM HOMEOSTASIS; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; HORMONAL REGULATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPENIA; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; RAT; SUBCUTANEOUS DRUG ADMINISTRATION; TIBIA;

EID: 0030730232     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.138.11.5505     Document Type: Article

References (21)

1. Tam CS, Heersche JNM, Murray TM, Parsons JA 1982 Parathyroid hormone stimulates the bone apposition rate independently of its resorption action: differential effects of intermittent and continuous administration. Endocrinology 110:506-512
2. Gunness-Hey M, Hock JM 1984 Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis 5:177-180
3. Riond J-L 1993 Modulation of the anabolic effect of synthetic human parathyroid hormone fragment-(1-34) in the bone of growing rats by variations in the dosage regimen. Clin Sci 85:223-228
4. May F, Jee WS, Ke HZ, Liu BY, Liang XG, Li M, Yamamoto N 1995 Human parathyroid hormone (1-38) restores cancellous bone to the immobilized osteopenic proximal tibial metaphysis in rats. J Bone Miner Res 10:496-505
5. Wronski TJ, Yen C-F, Dann LM 1993 Parathyroid hormone is more effective than estrogen or bisphosphonates for restoration of lost bone mass in ovariectomized rats. Endocrinology 132:823-831
6. Liu CC, Kalu DN 1990 Human parathyroid hormone (1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J Bone Miner Res 5:973-982
7. Hori M, Uzawa T, Morita K, Noda T, Takahashi H, Inoue J 1988 Effect of human parathyroid hormone [PTH (1-34)] on experimental osteopenia in rats induced by ovariectomy. J Bone Miner Res 3:193-199
8. Hock JM, Gera I, Ponseca J, Raisz LG 1988 Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats. Endocrinology 122:2899-2904
9. Kalu DN, Echon R, Hollis BW 1990 Modulation of ovariectomy-related bone loss by parathyroid hormone in rats. Mech Aging Dev 56:49-62
10. Hock JM, Fonseca J 1990 Anabolic effect of human synthetic parathyroid hormone-(1-34) depends on growth hormone. Endocrinology 127:1804-1810
11. Schmidt IU, Dobnig H, Turner RT 1995 Intermittent parathyroid hormone treatment increases osteoblast number, steady-state messenger ribunucleic acid levels for osteocalcin, and bone formation in tibial metaphysis of hypophysectomized female rats. Endocrinology 136:5127-5134
12. Dobnig H, Turner RT 1995 Evidence that intermittent treatment with parathyroid hormone increases bone formation in adult rats by activation of bone lining cells. Endocrinology 136:3632-3638
13. Leaffer D, Sweeney M, Kellerman LA, Avnur Z, Krstenansky JL, Vickery BH, Caulfield JF 1995 Modulation of osteogenic cell ultrastructure by RS-23581, an analog of human parathyroid hormone (PTH)-related peptide-(1-34), and bovine PTH-(1-34). Endocrinology 136:3624-3631
14. Mosekilde L, Reeve J 1996 Treatment with PTH peptides. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, New York, pp 1293-1311
15. Dempster DW, Cosman F, Parisien M, Shen V, Lindsay R 1993 Anabolic actions of parathyroid hormone on bone. Endocr Rev 14:690-709
16. Heath III H 1996 Primary hyperparathyroidism, hyperparathyroid bone disease, and osteoporosis. In: Marcus R, Feldman D, Kelsey J (eds) Osteoporosis. Academic Press, New York, pp 885-897
17. Parfitt AM, Mathews CH, Villanueva AR, Kleerekoper M, Frame B, Rao DS 1983 Relationships between surface, volume and thickness of iliac trabecular bone in aging and osteoporosis: implications for the microanatomic and cellular mechanisms of bone loss. J Clin Invest 72:1396-1409
18. Kent GN, Loveridge N, Reeve J, Zanelli JM 1985 Pharmokinetics of synthetic human parathyroid hormone 1-34 in man measured by cytochemical bioassay and radioimmunoassay. Clin Sci 68:171-177
19. Turner RT 1984 Mammalian 25-hydroxyvitamin D-1α-hydroxylase: measurement and regulation. In: Kumar R (ed) Vitamin D Metabolism: Basic and Clinical Aspects. Martinus Nihoff, Boston, pp 175-196
20. 2D synthesis. Am J Med Sci 296:417-425
21. Worstman J, Haddad JG, Posillico JT, Brown EM 1996 Primary hyperparathyroidism with low serum 1,25-dihydroxyvitamin D levels. J Clin Endocrinol Metab 62:1305-1308